- Home
- SARS-CoV-2 Omicron Spike Antigens
- SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)
The Native Antigen
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293)
- SKU:
- REC32006
- UPC:
- MPN:
Description
SARS-CoV-2 (B.1.1.529/Omicron) Spike Glycoprotein (S1), Sheep Fc-Tag (HEK293) | REC32006 from Native Antigen is available for delivery.
SARS-CoV-2 (B.1.1.529/Omicron) Spike subunit 1 protein. Relative to Wuhan-Hu-1 this protein has following amino acid changes: A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y. SARS-CoV-2, previously known as the 2019 Novel Coronavirus (2019-nCoV), causes the pandemic COVID-19 disease.
PRODUCT DETAILS – SARS-COV-2 (B.1.1.529/OMICRON) SPIKE GLYCOPROTEIN (S1) RBD, SHEEP FC-TAG (HEK293)
- SARS-CoV-2 (B.1.1.529/Omicron) spike (Accession: GISAID EPI_ISL_6795838)
- SARS-CoV-2 (B.1.1.529/Omicron) spike contains A67V, H69del, V70del, T95I, G142D, V143del, Y144del, Y145del, N211del, L212I, ins214EPE, G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, Y505H, T547K, D614G, H655Y mutations relative to Wuhan Hu-1.
- Expressed in HEK293 and purified by affinity chromatography.
- Presented in liquid form at high purity.
BACKGROUND
South Africa reported the identification of a new SARS-CoV-2 variant, B.1.1.529, to the World Health Organization (WHO) on November 24, 2021. B.1.1.529 was first detected in specimens collected in Botswana and South Africa. On December 1, 2021, the first case attributed to B.1.1.529 was reported in the United States in a person who returned from travel to South Africa. The Omicron variant has since been detected in travel-related cases in an increasing number of European countries, as well as Australia, Brazil, Canada, Hong Kong, Israel, Japan, Nigeria, Norway, Sweden, and the United Kingdom. A few countries, including the United States, have reported cases in individuals without travel history to southern Africa.
On November 26, 2021, the Technical Advisory Group on SARS-CoV-2 Virus Evolution (TAG-VE) convened to assess B.1.1.529. The TAG-VE advised WHO that this variant should be designated as a Variant of Concern (VOC), and WHO designated B.1.1.529 as a VOC named Omicron. The European Center for Disease Prevention and Control also classified this variant as a VOC due to concerns regarding immune escape and potentially increased transmissibility compared to the Delta variant.
Omicron has a large number of spike protein substitutions, some of which are known from other variants to be associated with reduced susceptibility to available monoclonal antibody therapeutics or reduced neutralization by convalescent and vaccinee sera. The spike protein of the Omicron variant is characterized by at least 30 amino acid substitutions, three small deletions, and one small insertion. Notably, 15 of the 30 amino acid substitutions are in the receptor binding domain (RBD). There are also a number of changes and deletions in other genomic regions. Some diagnostic kits have significantly reduced S-gene target sensitivity due to the deletion at H69 and V70 in the B Omicron spike protein. Specimens being tested using these kits that yield an S gene target failure (SGTF) ‘may’ be Omicron (CDC, 2021).
REFERENCES
- Science Brief: Omicron (B.1.1.529) Variant (CDC).
- Classification of Omicron (B.1.1.529): SARS-CoV-2 Variant of Concern (WHO).
- Threat Assessment Brief: Implications of the emergence and spread of the SARS-CoV-2 B.1.1. 529 variant of concern (Omicron) for the EU/EEA (ECDC).
Related Products

Recombinant SARS-CoV-2 Spike S1 (D614G) , ECD (Fc Tag) | 763-PKSV030395
Elabscience

Recombinant SARS-CoV-2 S1+S2 Protein (ECD, C-His Tag) (Omicron) | PKSV030471
Elabscience

Recombinant SARS-CoV-2 Spike S1 NTD Protein (ECD, C-His Tag) (Omicron) | PKSV030473
Elabscience

Recombinant SARS-CoV-2 Spike S1 Protein (C-His Tag) (Omicron) | PKSV030480
Elabscience

SARS-CoV-2 Spike Glycoprotein-crude (B.1.1.529-Omicron) | S-CP-P2010
Elabscience

SARS-CoV-2 Spike Glycoprotein | GEN-P0DTC2
Gentaur
Customers Also Viewed


COVID-19 Spike Protein Accquant® ELISA Kit
Fine Test

abm | Partial ORF1ab 18500-19500 Fragment RNA Control | G632-17
ABM Good

abm | Partial ORF1ab 12500-13500 Fragment RNA Control | G632-15
ABM Good


SARS-CoV-2 S Protein RBD | abx163964
abbexa


SARS-CoV-2 S1 Protein RBD (Beta B.1.351 Variant) | abx160085
abbexa

SARS-CoV-2 Y14 | GEN-P0DTD3
Gentaur

SARS-CoV-2 M | GEN-P0DTC5
Gentaur

SARS-CoV-2 E | GEN-P0DTC4
Gentaur

SARS-CoV-2 N | GEN-P0DTC9
Gentaur

SARS-CoV-2 ORF3a | GEN-P0DTC3
Gentaur

SARS-CoV-2 N | S-CP-P2009
Elabscience

SARS-CoV-2 Spike Glycoprotein-crude (B.1.1.529-Omicron) | S-CP-P2010
Elabscience

Recombinant SARS-CoV-2 Spike RBD Protein (mFc Tag) (Omicron) | PKSV030474
Elabscience

Recombinant SARS-CoV-2 Spike S1 NTD Protein (ECD, C-His Tag) (Omicron) | PKSV030473
Elabscience

Recombinant SARS-CoV-2 Spike Protein (RBD, mFc Tag) (V367F) | 763-PKSV030401
Elabscience

Recombinant 2019-nCoV Spike/RBD Protein (RBD, His Tag) | 763-PKSR030507
Elabscience

Recombinant 2019-nCoV NP NTD domain (His Tag) | 763-PKSR030486
Elabscience

Recombinant 2019-nCoV Spike Protein (NTD, His Tag) | 763-PKSR030484
Elabscience

Recombinant 2019-nCoV S1 Protein (mFc Tag) | 763-PKSR030479
Elabscience

Recombinant 2019-nCoV Spike Protein (RBD, His Tag) | 763-PKSR030475
Elabscience

Recombinant 2019-nCoV Spike Protein (RBD, mFc Tag) | 763-PKSR030474
Elabscience

CleanPlex SARS-CoV-2 Panel (8) | 918010
BioServUK

Recombinant SARS-CoV-2 Spike S1 Protein, polyhistidine tag | LTP-V006
BioServUK

SARS-CoV-2 (2019-nCoV) Spike Protein (S2 ECD, His tag) | BSV-COV-PR-06
BioServUK

SARS-CoV-2 (2019-nCoV) Spike Protein (S1+S2 ECD, His tag) | BSV-COV-PR-05
BioServUK

SARS-CoV-2 (2019-nCoV) Spike Protein (RBD, mFc Tag) | BSV-COV-PR-01
BioServUK

TMB Chromogen (in dimethylsulfoxide) (500 ul) | R4-01
BioServUK

Coronavirus SARS-CoV-2 Spike RBD Protein, polyhistidine tag | LTP-V009-1mg
BioServUK

2019 nCoV/COVID19 RBD domain of spike recombinant protein (S), Biotinylated | BSV-COV-PR-46
BioServUK

2019 nCoV/COVID19 RBD domain of spike recombinant protein (S)- Fc tag | BSV-COV-PR-44
BioServUK

2019 nCoV/COVID19 Spike protein S Recombinant (S1+S2), His-tag | BSV-COV-PR-40
BioServUK

Elite Anti-SARS-CoV-2 Nucleocapsid Protein Monoclonal Antibody, Clone CONδ-4 | BSV-N-04-0.1mg
BioServUK

Recombinant COVID-19 Omicron RBD (G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493K, G496S, Q498R, N501Y, Y505H) protein, His-Avi-tagged, Biotinylated
Creative BioMart

SARS-CoV-2 (B.1.1.529/Omicron) Stabilized Spike Glycoprotein (Trimeric), His-Strep-Tag (HEK293)
The Native Antigen

abm | ORF1ab and S Gene 21194 – 22194 Fragment cDNA Control | G633-4
ABM Good

abm | Partial ORF1ab - Partial S Gene 28259 – 29258 Fragment RNA Control | G632-9
ABM Good

abm | SARS-CoV-2 Synthetic RNA Control | G632-10
ABM Good

abm | Sample Collection and Viral Transport Solution | G631
ABM Good

abm | SARS-CoV-2 ORF1ab Recombinant Protein (Mammalian-Cell) | COV01032
ABM Good

abm | SARS-CoV-2 ORF1ab Protein, partial (Baculovirus) | COV01031
ABM Good

abm | SARS-CoV-2 ORF1ab Recombinant Protein, partial (E.coli) | COV01030
ABM Good

abm | SARS-CoV-2 N-S Fusion (NY-sp1) Recombinant Protein | COV01013
ABM Good

abm | SARS-CoV-2 N-S Fusion (NX-sp12) Recombinant Protein | COV01010
ABM Good

abm | SARS-CoV-2 Guanine-N7 Methyltransferase Recombinant Protein | COV01007
ABM Good


SARS-CoV-2 Nucleocapsid Protein Antibody | abx229490
abbexa


SARS-CoV-2 Nucleocapsid Protein Antibody | abx229489
abbexa


SARS-CoV-2 Envelope Protein Antibody | abx226552
abbexa


SARS-CoV-2 Trimeric Spike 1 Protein Antibody | abx024240
abbexa


SARS-CoV-2 Spike Protein RBD (S477N Mutation) | abx620008
abbexa


SARS-CoV-2 Spike Protein RBD (Delta B.1.617.2 Variant) | abx620012
abbexa